Eli Lilly (NYSE: LLY)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.130 | 2.620 | 0.4900 | ||||
REV | 6.680B | 7.810B | 1.130B |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Eli Lilly (NYSE: LLY) through any online brokerage.
Other companies in Eli Lilly’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Eli Lilly (NYSE: LLY) was reported by JP Morgan on Wednesday, June 1, 2022. The analyst firm set a price target for 355.00 expecting LLY to rise to within 12 months (a possible 9.32% upside). 26 analyst firms have reported ratings in the last year.
The stock price for Eli Lilly (NYSE: LLY) is $324.73 last updated July 1, 2022, 8:00 PM UTC.
The next Eli Lilly (LLY) dividend date is projected to be Friday, August 12, 2022.
Eli Lilly’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Eli Lilly.
Eli Lilly is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.